Sinopharm Group Co Ltd

01099

Company Profile

  • Business description

    Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm’s largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm’s total revenue. Sinopharm’s downstream customers range from hospitals and other health services institutions to end-customers.

  • Contact

    No. 385, East Longhua Road
    Sinopharm Group Building
    Huangpu District
    Shanghai200023
    CHN

    E: [email protected]

    http://www.sinopharmgroup.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    31 December 2024

    Employees

    113,635

Sinopharm Group Co Ltd News & Analysis

stocks

5 Asian stocks for your pick list

These China and Hong Kong listed companies are well placed amid the post-covid race to economic recovery, say Morningstar analysts.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,450.9064.30-0.76%
CAC 407,252.5925.610.35%
DAX 4019,107.9574.310.39%
Dow JONES (US)43,910.98382.15-0.86%
FTSE 1008,054.9329.160.36%
HKSE19,823.4523.43-0.12%
NASDAQ19,281.4017.36-0.09%
Nikkei 22538,721.66654.43-1.66%
NZX 50 Index12,674.4974.87-0.59%
S&P 5005,983.9917.36-0.29%
S&P/ASX 2008,193.4062.20-0.75%
SSE Composite Index3,439.2817.310.51%

Market Movers